The introduction of nicotinamide being a nicotine substitute in e-cigarette and smokeless products represents a significant regulatory challenge for the FDA. Nicotinamide doesn't have nicotinic receptor agonist action and is known to work as a sedative at superior dosages6. The promises created by Nicotine River, ECBlend, and various distributors t